Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 09:25 am Sale |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RTW INVESTMENTS LLC | 177 6.960% |
-1 (-0.61%) |
Filing History |
| 2021-02-10 9:17 pm Purchase |
2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
RENAISSANCE TECHNOLOGIES LLC | 156 5.810% |
156 (New Position) |
Filing History |
| 2021-02-09 08:30 am Unchanged |
2021-02-09 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 1,081 40.200% |
0 (Unchanged) |
Filing History |
| 2020-11-27 2:30 pm Purchase |
2020-11-17 | 13G | Aptevo Therapeutics Inc. APVO |
HIRSCHMAN ORIN | 75 2.950% |
75 (New Position) |
Filing History |
| 2020-11-18 5:03 pm Unchanged |
2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 1,081 42.500% |
0 (Unchanged) |
Filing History |
| 2020-11-16 11:02 am Purchase |
2020-11-05 | 13G | Aptevo Therapeutics Inc. APVO |
RTW INVESTMENTS LLC | 178 8.970% |
178 (New Position) |
Filing History |
| 2020-11-06 4:52 pm Purchase |
2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO |
TANG CAPITAL PARTNERS LP | 1,081 54.400% |
1,081 (New Position) |
Filing History |